AR and urinary bladder carcinoma: Previous studies suggested that AR activation induced resistance to conventional non-surgical therapy for bladder cancer [10], including intravesical BCG immunotherapy [93], intravesical or systemic chemotherapy [94–97], and radiotherapy [98].